annual FCF:
-$154.38M-$12.51M(-8.82%)Summary
- As of today (September 14, 2025), RYTM annual free cash flow is -$154.38 million, with the most recent change of -$12.51 million (-8.82%) on December 31, 2024.
- During the last 3 years, RYTM annual FCF has fallen by -$2.94 million (-1.94%).
- RYTM annual FCF is now -2180.68% below its all-time high of -$6.77 million, reached on December 31, 2015.
Performance
RYTM Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$23.31M+$17.04M(+42.22%)Summary
- As of today (September 14, 2025), RYTM quarterly free cash flow is -$23.31 million, with the most recent change of +$17.04 million (+42.22%) on June 30, 2025.
- Over the past year, RYTM quarterly FCF has increased by +$5.76 million (+19.82%).
- RYTM quarterly FCF is now -575.15% below its all-time high of -$3.45 million, reached on December 1, 2015.
Performance
RYTM quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$108.22M+$5.76M(+5.06%)Summary
- As of today (September 14, 2025), RYTM TTM free cash flow is -$108.22 million, with the most recent change of +$5.76 million (+5.06%) on June 30, 2025.
- Over the past year, RYTM TTM FCF has increased by +$60.50 million (+35.86%).
- RYTM TTM FCF is now -3034.20% below its all-time high of -$3.45 million, reached on December 1, 2015.
Performance
RYTM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
RYTM Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.8% | +19.8% | +35.9% |
| 3 y3 years | -1.9% | +45.6% | +40.7% |
| 5 y5 years | -22.4% | +21.6% | +18.0% |
RYTM Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.8% | +13.1% | -23.7% | +71.1% | at high | +42.8% |
| 5 y | 5-year | -26.3% | +13.1% | -23.7% | +71.1% | at high | +42.8% |
| alltime | all time | -2180.7% | +13.1% | -575.1% | +71.1% | -3034.2% | +42.8% |
RYTM Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$23.31M(-42.2%) | -$108.22M(-5.1%) |
| Mar 2025 | - | -$40.35M(+114.1%) | -$113.99M(-26.2%) |
| Dec 2024 | -$154.38M(+8.8%) | -$18.84M(-26.7%) | -$154.38M(-6.4%) |
| Sep 2024 | - | -$25.71M(-11.6%) | -$164.92M(-2.3%) |
| Jun 2024 | - | -$29.08M(-64.0%) | -$168.72M(-7.1%) |
| Mar 2024 | - | -$80.74M(+174.8%) | -$181.61M(+28.0%) |
| Dec 2023 | -$141.87M(-20.2%) | -$29.38M(-0.5%) | -$141.87M(-3.2%) |
| Sep 2023 | - | -$29.52M(-29.6%) | -$146.49M(-10.7%) |
| Jun 2023 | - | -$41.97M(+2.4%) | -$164.05M(-0.5%) |
| Mar 2023 | - | -$41.00M(+20.6%) | -$164.95M(-7.2%) |
| Dec 2022 | -$177.71M(+17.3%) | -$34.00M(-27.8%) | -$177.71M(-6.1%) |
| Sep 2022 | - | -$47.08M(+9.8%) | -$189.25M(+3.7%) |
| Jun 2022 | - | -$42.87M(-20.3%) | -$182.43M(+6.3%) |
| Mar 2022 | - | -$53.76M(+18.0%) | -$171.65M(+13.3%) |
| Dec 2021 | -$151.44M(+23.9%) | -$45.54M(+13.1%) | -$151.44M(+12.1%) |
| Sep 2021 | - | -$40.27M(+25.5%) | -$135.10M(+10.7%) |
| Jun 2021 | - | -$32.09M(-4.3%) | -$122.00M(+2.0%) |
| Mar 2021 | - | -$33.54M(+14.8%) | -$119.64M(-2.1%) |
| Dec 2020 | -$122.19M | -$29.21M(+7.5%) | -$122.19M(-2.4%) |
| Sep 2020 | - | -$27.16M(-8.6%) | -$125.21M(-5.1%) |
| Jun 2020 | - | -$29.73M(-17.6%) | -$131.91M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$36.10M(+12.0%) | -$130.04M(+3.1%) |
| Dec 2019 | -$126.14M(+100.9%) | -$32.22M(-4.9%) | -$126.14M(+9.4%) |
| Sep 2019 | - | -$33.86M(+21.5%) | -$115.29M(+16.8%) |
| Jun 2019 | - | -$27.86M(-13.4%) | -$98.69M(+18.4%) |
| Mar 2019 | - | -$32.19M(+50.6%) | -$83.32M(+32.7%) |
| Dec 2018 | -$62.78M(+112.1%) | -$21.38M(+23.9%) | -$62.78M(+27.2%) |
| Sep 2018 | - | -$17.26M(+38.2%) | -$49.34M(+21.6%) |
| Jun 2018 | - | -$12.49M(+7.2%) | -$40.58M(+18.5%) |
| Mar 2018 | - | -$11.65M(+46.7%) | -$34.23M(+15.7%) |
| Dec 2017 | -$29.59M(+21.9%) | -$7.94M(-6.5%) | -$29.59M(+36.7%) |
| Sep 2017 | - | -$8.49M(+38.3%) | -$21.65M(+64.6%) |
| Jun 2017 | - | -$6.14M(-12.5%) | -$13.16M(-3.6%) |
| Mar 2017 | - | -$7.02M(+5.7%) | -$13.65M(-19.9%) |
| Dec 2016 | -$24.28M(+258.6%) | - | - |
| Jun 2016 | - | -$6.63M(-4.5%) | -$17.04M(+63.8%) |
| Mar 2016 | - | -$6.95M(+101.2%) | -$10.40M(+201.2%) |
| Dec 2015 | -$6.77M(-9.8%) | - | - |
| Dec 2015 | - | -$3.45M | -$3.45M |
| Dec 2014 | -$7.51M(-60.8%) | - | - |
| Dec 2013 | -$19.16M(+7.4%) | - | - |
| Dec 2012 | -$17.83M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual free cash flow?
- What is the all time high annual FCF for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual FCF year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly FCF year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM FCF year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual free cash flow?
The current annual FCF of RYTM is -$154.38M
What is the all time high annual FCF for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual free cash flow is -$6.77M
What is Rhythm Pharmaceuticals, Inc. annual FCF year-on-year change?
Over the past year, RYTM annual free cash flow has changed by -$12.51M (-8.82%)
What is Rhythm Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly FCF of RYTM is -$23.31M
What is the all time high quarterly FCF for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly free cash flow is -$3.45M
What is Rhythm Pharmaceuticals, Inc. quarterly FCF year-on-year change?
Over the past year, RYTM quarterly free cash flow has changed by +$5.76M (+19.82%)
What is Rhythm Pharmaceuticals, Inc. TTM free cash flow?
The current TTM FCF of RYTM is -$108.22M
What is the all time high TTM FCF for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM free cash flow is -$3.45M
What is Rhythm Pharmaceuticals, Inc. TTM FCF year-on-year change?
Over the past year, RYTM TTM free cash flow has changed by +$60.50M (+35.86%)